Video: Who Am I?| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Varicella Zoster Virus Not Associated with Giant Cell Arteritis Pathogenesis

Carina Stanton  |  February 4, 2020

Researchers suggest antiviral therapy is not appropriate for patients with GCA, based on their study findings and related research…

Filed under:ConditionsVasculitis Tagged with:GCAgiant cell arteritis (GCA)varicella zoster virus

Update on the Management of Takayasu Arteritis

Lara C. Pullen, PhD  |  February 4, 2020

A rare form of large vessel vasculitis, Takayasu arteritis persents with no clear patterns, with patients experiencing vascular symptoms, as well as such systemic symptoms as fever and weight loss. A systematic literature review found evidence to guide rheumatologists in monitoring and treating their patients with Takayasu arteritis…

Filed under:ConditionsVasculitis Tagged with:large-vessel vasculitisTakayasu’s ArteritisVasculitis

Canada & E.U. Approve Upadacitinib for RA

Michele B. Kaufman, PharmD, BCGP  |  January 28, 2020

Upadacitinib will soon be available to treat patients with moderate to severe rheumatoid arthritis in Canada and the E.U…

Filed under:Biologics/DMARDsDrug Updates Tagged with:CanadaEuropean UnionRheumatoid Arthritis (RA)U.S. Food and Drug Administration (FDA)upadacitinib

Increased Risk of Inflammatory Arthritis with Hidradenitis Suppurativa

Will Boggs, MD  |  January 27, 2020

NEW YORK (Reuters Health)—Patients with hidradenitis suppurativa face an increased risk of developing inflammatory arthritis, according to findings from a claims database. “We observed increased risks of developing ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis (RA) among patients with hidradenitis suppurativa when compared with those without hidradenitis suppurativa,” says Maria C. Schneeweiss, MD, of Brigham…

Filed under:Axial SpondyloarthritisConditions Tagged with:Hidradenitis suppurativaInflammatory arthritisrisk

New Gabapentinoid Warning Labels

Michele B. Kaufman, PharmD, BCGP  |  January 23, 2020

Gabapentinoid products will now carry warning labels about the risks of respiratory distress when combined with opioids and other nervous system and respiratory depressants…

Filed under:Uncategorized Tagged with:Drug SafetyFDAgabapentinoidsU.S. Food and Drug Administration (FDA)

Support Pediatric Subspecialty Loan Repayment to Boost Workforce Growth

Tamar Rubinstein, MD, MS  |  January 21, 2020

Current legislation that stipulates a loan repayment program for pediatric subspecialists could help the pediatric rheumatology community attract trainees and meet patient demand.

Filed under:Education & TrainingWorkforce Tagged with:ACR Workforce StudyGovernment Affairs Committee (GAC)loan repaymentPediatric Rheumatologyworkforce development

Tips for Smoothing the Time-Consuming Prior Authorization Process

Susan Bernstein  |  January 17, 2020

ATLANTA—Obtaining prior authorization to ensure services or prescription drugs are covered by a patient’s health plan consumes staff time, and delays or denials may cause patients to abandon treatment, according to speakers at the 2019 ACR/ARP Annual Meeting. In a session on Nov. 10, the experts shared tips to smooth the process. Train Staff on…

Filed under:Practice SupportWorkforce Tagged with:2019 ACR/ARP Annual Meetingpharmacy benefit managers (PBMs)prior authorizationstep therapy

Clinical Pearls for Diagnosing & Treating Sjögren’s Syndrome

Jason Liebowitz, MD, FACR  |  January 17, 2020

ATLANTA—Dry eyes and mouth are common symptoms in the general population. When patients report these symptoms to their primary care provider and other consultants, it may prompt a referral to a rheumatologist to rule out Sjögren’s syndrome. However, as discussed in the 2019 ACR/ARP Annual Meeting session, Sjögren’s Syndrome: Beyond the Dryness, evaluation of this…

Filed under:ConditionsSjögren’s Disease Tagged with:2019 ACR/ARP Annual MeetingSjogren's

Tips for Engaging Your Pediatric Research Patients

Susan Bernstein  |  January 17, 2020

ATLANTA—Around 2002, when Vincent Del Gaizo’s son was just 15 months old, he was hospitalized in an intensive care unit and, weeks later, was diagnosed with systemic juvenile idiopathic arthritis (JIA). “We had the same 8 trillion questions that all parents have when their child is diagnosed with a condition you’ve never heard of: ‘Is…

Filed under:Patient PerspectiveProfessional Topics Tagged with:2019 ACR/ARP Annual MeetingChildhood Arthritis and Rheumatology Research AlliancePatient-Centered Outcomes Research Institute (PCORI)Pediatric-Rheumatology Care and Outcome Improvement Network (PR-COIN)

Tele-Rheumatology Offers Lots of Benefits

Thomas R. Collins  |  January 17, 2020

ATLANTA—With growing demand for access to rheumatologists in rural areas, a shortage in the number of rheumatologists and the ability to use technology as a bridge to patients in remote areas, telemedicine seems like a smart option. And it certainly can be, experts said at a 2019 ACR/ARP Annual Meeting session in November. But a…

Filed under:Practice SupportTechnology Tagged with:2019 ACR/ARP Annual Meetingtelemedicine

  • « Previous Page
  • 1
  • …
  • 109
  • 110
  • 111
  • 112
  • 113
  • …
  • 326
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences